According to a new market report published by Lucintel,
the future of the global stent market looks promising with opportunities in the
segments of hospital and ambulatory surgical centers. The global stent market
is expected to reach an estimated $10.8 billion by 2024 with a CAGR of 3.3%
from 2019 to 2024. The major growth drivers for this market are increasing interventional
cardiology and peripheral vascular procedures and rising adoption of
technological advancements in an effort to reduce treatment duration for high
risk conventional surgical patients.
In this market, coronary stents and peripheral vascular
stents are the main types of stents used in interventional cardiology and
peripheral vascular procedures. On the basis of
comprehensive research, Lucintel forecasts that the coronary stent segment will
show above average growth during the forecast period due to increasing cases of
cardiovascular disorders.
Within the global stent market, the drug eluting stent segment
will remain the largest market by technology during the forecast period due to low
restenosis rate after surgery. Bioreabsorbable stent is expected to witness the
highest growth during the forecast period due to its property of getting
absorbed in the body.
By material, the global stent market is segmented into
metal and polymer. The polymer segment is expected to remain the largest segment
in the forecast period.
North America is expected to remain the largest market
during the forecast period mainly due to its well-developed healthcare
infrastructure and continued technological advancements across the healthcare
industry.
Emerging trends which have a direct impact on
the dynamics of the market include increasing use of bioreabsorbable stent, increasing adoption of co-polymers
as raw materials, and increasing adoption of bifurcated stents. Abbott
Laboratory, Boston Scientific, Medtronic public limited company, C R Bard, Cook Medical Inc., Terumo
Corporation, and Cardinal Health Inc. are among the major suppliers of stents.
Lucintel, a
leading global strategic consulting and market research firm, has analyzed
growth opportunities in the global stent market by product type, material, technology,
end use, and region, and has compiled a comprehensive research report entitled “Growth Opportunities in the
Global Stents Market 2019-2024: Trends, Forecast, and Opportunity Analysis.”
The Lucintel report serves as a catalyst for growth strategy by providing comprehensive
data and analysis on trends, key drivers, and directions. The study includes a
forecast for the global stent market by product type, material, technology, end use, and region, as
follows:
By Product Type
[Value ($ Million) and Volume (Million Units) from 2013 to 2024]:
· Coronary
Stents
· Peripheral
Vascular Stents
By Material [Value
($ Million) and Volume (Million Units) from 2013 to 2024]:
· Metal
· Polymer
By Technology
[Value ($ Million) and Volume (Million Units) from 2013 to 2024]:
· Bare Metal
Stents
· Drug Eluting
Stents
· Bioreabsorbable
Stents
By End Use [Value ($ Million)]:
· Hospital
· Ambulatory
Surgical Center
By Region [Value
($ Million) and Volume (Million Units) from 2013 to 2024]:
· North America
− United States
− Canada
− Mexico
· Europe
− Germany
− France
− United Kingdom
− Italy
− Spain
· APAC
− China
− India
− Japan
· ROW
− Brazil
This
188-page research report will enable you to make confident business decisions
in this globally competitive marketplace. For a detailed table of contents,
contact Lucintel at +1-972-636-5056 or helpdesk@lucintel.com.
Lucintel offerings include medical
market analysis, medical
market research, strategic
growth consulting, market research due
diligence and business
strategy consulting.
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity analysis, growth consulting, M&A, and due diligence
services to executives and key decision-makers in a variety of industries. For
further information, visit www.lucintel.com.
This report addresses the following key
questions:
Q. 1. What are some of the most promising,
high-growth opportunities for the global stent market by product type (coronary
stent and peripheral vascular stent), material (metal and polymer), technology
(bare metal stent, drug eluting stent, and bioreabsorbable stent), end use (hospital
and ambulatory surgical center), and region (North America, Europe, Asia
Pacific, and the Rest of the World)?
Q. 2. Which product segment will grow at a
faster pace and why?
Q. 3. Which region will grow at a faster pace
and why?
Q.4. What are the key factors affecting
market dynamics? What are the drivers, challenges, and business risks in this market?
Q.5. What are the business risks and competitive
threats in this market?
Q.6. What are the emerging trends in this
market and the reasons behind them?
Q.7. What are some of the changing demands of
customers in the market?
Q.8. What are the new developments in the
market and which companies are leading these developments?
Q.9. Who are the major players in this
market? What strategic initiatives are being taken by key companies for
business growth?
Q.10. What are some of the competing products
in this market and how big of a threat do they pose for loss of market share by
product substitution?
Q. 11. What M&A activity has occurred in
the last 5 years?
